在前列腺癌中,当XRCC1表达减少时,PARP抑制剂反应会增强
Kaveri Goel1, Vani Venkatappa2, Kimiko L Krieger2
1Department of Pathology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, United States.
NAR cancer
|April 24, 2025
概括
低表达的DNA修复蛋白XRCC1预测前列腺癌 (PCa) 对PARP抑制剂 (PARPis) 的反应. 这一发现将潜在的PARPi治疗扩展到更多具有低XRCC1水平的mCRPC患者.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 前列腺癌 (PCa) 是男性癌症死亡的主要原因,转移性割抵抗性PCa (mCRPC) 构成重大管理挑战.
- 多 (ADP-ribose) 聚合酶抑制剂 (PARPis) 对mCRPC具有前景,特别是在具有同源重组修复 (HRR) 缺陷的瘤中.
- 对PARPis的耐药性和有限数量的HRR缺陷的mCRPC患者需要确定新的治疗点.
研究的目的:
- 研究XRCC1 (一种DNA修复蛋白) 在前列腺癌中PARPi敏感性中的作用.
- 为了确定低XRCC1表达是否可以预测对mCRPC中PARP抑制剂 (PARPis) 的反应.
主要方法:
- 在前列腺癌患者队列中分析XRCC1表达水平.
- 生成XRCC1缺陷前列腺癌模型以评估PARPi灵敏度.
- 利用多西环素诱导系统证实了XRCC1表达和PARPi反应之间的相关性.
主要成果:
- 在前列腺癌患者中,XRCC1的表达有显著的变化,许多患者表现出低水平.
- 在PCa模型中XRCC1缺乏导致对PARPis的过敏,其特征是DNA双链断裂增加,细胞循环停止和细胞亡.
- 证实了XRCC1表达水平和对PARPi治疗的敏感性之间的直接相关性.
结论:
- XRCC1表达水平是前列腺癌中PARPi反应的预测生物标志物.
- PARPis的临床应用可以扩展到低XRCC1表达的前列腺癌患者.
- 针对XRCC1缺陷提供了一种潜在的策略,以克服mCRPC中的PARPi抗性.
更多相关视频
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.7K
10:44Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
Published on: January 31, 2018
10.2K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
